Print

Lay Description

• To determine the optimal time to initiate anticoagulation with a Non-Vitamin K Oral Anticoagulant (NOAC) after ischemic stroke in patients with non-valvular atrial fibrillation.

Secondary Objectives:

  • To compare the rates of primary adverse outcomes in a per protocol analysis
  • To compare 30 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups
  • To compare 30 day clinical outcomes by the PROMIS-10 scale among the time-to-treatment groups.
  • To compare 90 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups
  • To explore the optimal timing in subgroups of age, sex, outcome category, and NOAC choice

Category

  • Heart, Vascular and Blood
IRB Number
20180802HU
NCT Number
NCT # not yet entered

Eligibility

Eligible Ages
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact

Principal Investigator
Donald McGeary